Paceline Investors

What Paceline Investors does

Paceline Investors is a privately-held commercial real estate investment firm headquartered at 242 California Street in San Francisco's Financial District, founded in 2015 by Jay Atkinson. The firm pursues a value-add strategy focused on acquiring underperforming, "languishing" Bay Area commercial properties—primarily office, R&D, lab, advanced manufacturing, and PDR/automotive assets—and executing hands-on renovation, building system upgrades, and lease-up to generate investment returns. Paceline does not develop technology products; its core offering is asset identification, capital structuring, physical repositioning, and active asset management, with a thematic concentration on STEM-industry tenant demand (life science, biotech, advanced manufacturing, and tech headquarters).

The firm operates a deal-by-deal investment model, aggregating capital alongside financial partners and institutional co-investors rather than running a commingled fund. Notable executions include the 11-building Harbor Bay Alameda Portfolio (~691,000 sf) assembled via 8 off-market transactions between December 2019 and June 2022, and the opportunistic 2026 purchase of 2581 Junction Ave. for $12.2 million—a 61.9% discount to the prior 2018 price. Paceline monetizes assets through a combination of operational NOI growth and eventual sale (e.g., 1019 Market Street sold 2014, 500 8th Street sold 2022 to Porsche, 1714-1720 Franklin Street sold 2024), with the firm retaining ongoing ownership of stabilized assets like Harbor Bay (93% leased, 10+ year WALT).

The team is intentionally small (1–10 employees) and combines institutional pedigree with operating experience: principals previously held roles at JLL, Trammell Crow, CBRE, and Newmark, while a dedicated lab operations lead brings 16+ years of operator experience at Amyris, Zymergen, Caribou, Just, and Neuralink. Paceline's go-to-market is relationship-driven rather than marketing-led, with sourcing channels centered on direct outreach to property owners, lenders, municipalities, and institutional investors in the Bay Area. Pricing and transaction terms are negotiated individually and not publicly disclosed.

Name

Paceline Investors

Legal name

Paceline Investors

Website

https://pacelineinvestors.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Paceline Investors is a privately-held San Francisco commercial real estate investment firm, founded in 2015, that acquires, renovates, and lease-ups undervalued Bay Area office, R&D, lab, and advanced manufacturing properties for STEM-industry tenants alongside co-investment partners.

Ownership category

akta.pro rank

Product category

Commercial Real Estate Investment

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Real Estate Dealers (For Their Own Account) (6532)

akta.pro primary industry

Real Estate Funds — Opportunistic / Development (FSANAEAI)

akta.pro secondary industry

Real Estate Portfolio & Fund Management (Institutional/REIT/PE) (BPAJAMAJ)

Keywords

• Commercial real estate investment
• Value-add real estate
• Property asset management
• STEM real estate
• Bay Area real estate

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Supply Chain, Others

Revenue model

1. Real Estate Investment Returns: Paceline Investors generates returns through appreciation in property values from active asset management, physical renovations, and lease-up strategies. The firm invests in underperforming commercial properties, enhances them physically, strengthens rent rolls, and generates investment returns through eventual sale or ongoing operations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Paceline Investors is a San Francisco-based commercial real estate investment firm that identifies overlooked, underperforming properties in the Bay Area and executes value-add strategies combining physical renovation, building system upgrades, and lease-up to generate investment returns. The firm focuses primarily on office, R&D, lab, and advanced manufacturing assets serving STEM industries, acquiring properties both on-market and off-market and operating them with hands-on asset management.

Product overview

Paceline Investors is a privately-owned commercial real estate investment firm headquartered in San Francisco, California, specializing in Bay Area value-add opportunities in STEM industries. The firm operates as a single unified service offering—commercial real estate investment and asset management—where the core product encompasses property acquisition, physical renovation, building system upgrades, and leasing to generate investment returns. Their portfolio includes multiple named property investments such as the Harbor Bay Alameda Portfolio (691k sf multi-tenant life science/office campus), 500 8th Street (PDR/Automotive), 20 Heron Street (R&D), 3500 West Warren Boulevard (R&D/Manufacturing), 1155 Bryant Street (R&D/Lab), 47200 Bayside Parkway (Office/R&D), and various other office, retail, and mixed-use properties across the Bay Area. Each investment follows a value-add strategy of acquiring under-appreciated properties requiring active business plans that combine physical renovation with leasing to target tenants.

Differentiator

Problem solved

Functional benefit

Products and services

• Value-Add Commercial Real Estate Investment Services Core investment and asset management service focused on acquiring underperforming Bay Area commercial properties, executing physical renovations and building system upgrades, leasing to creditworthy tenants, and generating returns through appreciation, NOI growth, and eventual sale.
• Harbor Bay Alameda Portfolio 11-building portfolio totaling approximately 691,000 square feet in Alameda, CA, comprising advanced manufacturing, HQ office, and multi-tenant lab/life science spaces; 93% leased with 10+ years weighted average lease term, including over 400,000 sf converted to life science/laboratory uses.
• 2581 Junction Avenue (North San Jose) Office and research building in North San Jose acquired for $12.2 million, representing a 61.9% discount versus the $32 million paid in 2018; currently leased to Ensurge Micropower, a battery technology company.
• 47200 Bayside Parkway Partial two-story office/R&D building in Fremont, CA with 4000 amp electrical service and lab-compatible mechanical systems, supporting STEM and life science tenants.
• 1155 Bryant Street 32,000 sf R&D/Lab building in San Francisco acquired September 2022 with new Lab and Office tenant improvements; 100% leased to a food technology company.

Quantifiable outcome

• 61.9% discount achieved on property acquisition vs. 2018 purchase price
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• TMG Partners: Bay Area-based commercial real estate developer and investor specializing in mixed-use, office, and life science projects. Comparable to Paceline in regional focus, value-add orientation, and tenant-driven repositioning.
• Harvest Properties: Bay Area value-add and core-plus commercial real estate investor with deep expertise in office, life science, and R&D/lab conversions. Comparable strategy of acquiring underperforming assets, executing physical repositioning, and leasing to high-credit tenants.
• Swift Real Estate Partners: San Francisco-based value-add commercial real estate investor focused on office, life science, and creative office properties in the Bay Area. Operates a closely comparable buy-reposition-sell strategy targeting STEM-adjacent tenants.
• SteelWave: Bay Area-focused commercial real estate investment and management firm with deep experience in office, life science, and R&D properties. Directly comparable in regional focus and asset class overlap with Paceline's portfolio.
• Cannae Partners: Bay Area-focused value-add commercial real estate investment firm co-founded by Jay Atkinson in 2010 (Paceline's founder). Operates with similar institutional capital partners and targets the same type of value-add STEM/life science opportunities in the Bay Area.
• Menlo Equities: Silicon Valley-focused value-add real estate investment manager specializing in office and life science properties. Closely comparable to Paceline in targeting R&D/lab conversions and STEM-tenant leasing in the Bay Area.
• Phase 3 Real Estate Partners: Bay Area-based value-add commercial real estate investor focused on office, R&D, and industrial properties. Operates a similar acquisition-renovation-disposition strategy and competes with Paceline for similar off-market opportunities.
• McCarthy Cook & Co: Bay Area and Southern California value-add commercial real estate investment manager focused on office, life science, and mixed-use properties. Closely comparable to Paceline in target asset classes, value-add execution, and institutional partnership model.
• srmERNST: San Francisco-based commercial real estate investment and management firm with deep Bay Area expertise across office, life science, and mixed-use assets. Comparable in regional focus and tenant-driven repositioning strategy.

Broad incumbents

• Lincoln Property Company: National commercial real estate investment, development, and management firm with a substantial Bay Area presence across office, life science, and industrial. Competes with Paceline for similar tenant pools and assets but at materially larger scale and broader geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/paceline-investors-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Paceline Investors